Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Drug Administration and Therapy Phases: Overview

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

Development of Antibiotic Resistance

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...

Production of Antibiotics

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Antihistaminics in pediatric age].

La Pediatria medica e chirurgica : Medical and surgical pediatrics·1995

Same author

Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation.

Infection·1991

Same author

Safety of oral ciprofloxacin. An update based on clinical trial results.

The American journal of medicine·1989

Same author

[Torsion of the spermatic cord in utero. Description of a clinical case in the neonatal period].

Minerva pediatrica·1988

Same author

A survey of clinical experience with ciprofloxacin, a new quinolone antimicrobial.

Journal of clinical pharmacology·1988

Same author

Worldwide clinical data on efficacy and safety of ciprofloxacin.

Infection·1988

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Process of developing a new antimicrobial drug.

Annals of Internal Medicine

|November 1, 1978

Summary

Developing new antimicrobial drugs faces significant hurdles, including discovery challenges, unpredictable preclinical studies, and difficulties in clinical trial design and patient enrollment. Addressing these issues is crucial for advancing antimicrobial drug development.

Area of Science:

Pharmaceutical Science
Drug Development
Infectious Diseases

Background:

The development pipeline for new antimicrobial drugs, from initial compound discovery to New Drug Application submission, is complex and faces numerous challenges.
A survey of 62 pharmaceutical companies identified key bottlenecks in the antimicrobial drug development process.

Purpose of the Study:

To review the antimicrobial drug development network and identify critical problems encountered by pharmaceutical companies.
To elucidate the specific challenges in discovering, testing, and clinically evaluating new antimicrobial compounds.

Main Methods:

A survey was conducted among 62 American pharmaceutical companies involved in drug development.
The survey focused on identifying key problems throughout the entire antimicrobial drug development process.

More Related Videos

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Production and Testing of Antimicrobial Peptides and Their Mimics

Production and Testing of Antimicrobial Peptides and Their Mimics

Published on: April 10, 2026

Related Experiment Videos

Last Updated: Jun 1, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Production and Testing of Antimicrobial Peptides and Their Mimics

Production and Testing of Antimicrobial Peptides and Their Mimics

Published on: April 10, 2026

Main Results:

Significant difficulties exist in the discovery of novel and effective antimicrobial agents.
Preclinical studies (in-vitro and animal models) show unpredictability, and criteria for therapeutic bacteriologic response are lacking.
Challenges include designing controlled clinical studies and enrolling appropriate patients with confirmed microbiologic diagnoses.

Conclusions:

The antimicrobial drug development pathway is fraught with predictable and unpredictable challenges.
Improvements in preclinical models, standardized clinical trial criteria, and efficient patient recruitment are necessary to overcome these obstacles.